Opiant Pharmaceuticals, Inc. (OPNT)

Today's Latest Price: $9.33 USD

0.17 (1.86%)

Updated Jan 22 4:00pm

Add OPNT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 239 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Opiant Pharmaceuticals Inc (OPNT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Opiant Pharmaceuticals Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
3 $44 $38 $41.33 $9.16 351.2%

OPNT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 0 2 0 0 0 NA

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The upside potential (average analyst target price relative to current price) of OPNT is higher than 94.96% of all US stocks.
  • OPNT has a higher average analyst price target than 93.78% of stocks in the micro market cap category.
  • The variance in analysts' estimates of OPNT is lower than 79.06% of Healthcare stocks.
  • Opiant Pharmaceuticals Inc's number of analysts covering the stock is greater than 23.85% of Healthcare stocks.
  • OPNT has a lower percent of analysts bearish on the stock than nearly 100% of all US stocks.
  • Opiant Pharmaceuticals Inc's percentage of analysts bullish on the stock is higher than nearly none of all US stocks.
  • Opiant Pharmaceuticals Inc's change in bullishness amongst analysts is lower than nearly 100% of all US stocks.

In the Non-Metallic and Industrial Metal Mining industry, USAU, MP and LAC are the three stocks most similar to Opiant Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Is OPNT a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7139 seconds.